News Digest / Lukas Schmidt

Author: Lukas Schmidt

08:49am, Wednesday, Nov 05, 2025
Novo Nordisk pares down growth projections for Ozempic and Wegovy as pricing pressure and competition intensify, sparking mixed reactions in a volatile market environment.